Emerging drugs for panic disorder

Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials

(2011) Luisa V. Lopes et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

New treatment options for panic disorder: clinical trials from 2000 to 2010

(2011) Rafael C Freire et al.   EXPERT OPINION ON PHARMACOTHERAPY

Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze

(2011) Vânia Ramos Sela et al.   NEUROSCIENCE LETTERS

Unstable Maternal Environment, Separation Anxiety, and Heightened CO2 Sensitivity Induced by Gene-by-Environment Interplay

(2011) Francesca R. D'Amato et al.   PLoS One

Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray

(2010) Lee Wei Lim et al.   EXPERIMENTAL NEUROLOGY

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

(2010) Michele Mancini et al.   EXPERT OPINION ON PHARMACOTHERAPY

A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses

(2010) Anantha Shekhar et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Adenosine A2A receptor gene: Evidence for association of risk variants with panic disorder and anxious personality

(2010) Christa Hohoff et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines

(2010) Alessandro Serretti et al.   NEUROPSYCHOBIOLOGY

Is there a hypersensitive visual alarm system in panic disorder?

(2010) Daniela Caldirola et al.   PSYCHIATRY RESEARCH

Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss

(2010) M. Preter et al.   PSYCHOLOGICAL MEDICINE

Panic Disorder Respiratory Subtype: Psychopathology, Laboratory Challenge Tests, and Response to Treatment

(2010) Rafael C. Freire et al.   HARVARD REVIEW OF PSYCHIATRY

Decreased Neurokinin-1 (Substance P) Receptor Binding in Patients with Panic Disorder: Positron Emission Tomographic Study with [18F]SPA-RQ

(2009) Yota Fujimura et al.   BIOLOGICAL PSYCHIATRY

Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder

(2009) Michael W. Otto et al.   BIOLOGICAL PSYCHIATRY

A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study

(2009) James M Prosser et al.   BMC Psychiatry

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

(2009) Karl Ebner et al.   CURRENT PHARMACEUTICAL DESIGN

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

(2009) Madhukar H. Trivedi et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

(2009) Michael R. Liebowitz et al.   JOURNAL OF CLINICAL PSYCHIATRY

Review: Acids in the brain: a factor in panic?

(2009) G. Esquivel et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A key role for orexin in panic anxiety

(2009) Philip L Johnson et al.   NATURE MEDICINE

Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3α,5α-tetrahydrodeoxycorticosterone concentrations

(2009) Peter Zwanzger et al.   PSYCHONEUROENDOCRINOLOGY

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

(2009) Rainer Rupprecht et al.   SCIENCE

Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia

(2008) F. J. van Apeldoorn et al.   ACTA PSYCHIATRICA SCANDINAVICA

Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder

(2008) Martin E. Keck et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Altered Cerebral γ-Aminobutyric Acid Type A–Benzodiazepine Receptor Binding in Panic Disorder Determined by [11C]Flumazenil Positron Emission Tomography

(2008) Gregor Hasler et al.   ARCHIVES OF GENERAL PSYCHIATRY

A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety

(2008) JE Bailey et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Panic, suffocation false alarms, separation anxiety and endogenous opioids

(2007) Maurice Preter et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY